BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37653425)

  • 1. Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML.
    Zhang Y; Jiang S; He F; Tian Y; Hu H; Gao L; Zhang L; Chen A; Hu Y; Fan L; Yang C; Zhou B; Liu D; Zhou Z; Su Y; Qin L; Wang Y; He H; Lu J; Xiao P; Hu S; Wang QF
    Genome Biol; 2023 Aug; 24(1):199. PubMed ID: 37653425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
    Cheng PL; Hsiao TH; Chen CH; Hung MN; Jhan PP; Lee LW; Wu TS; Tsai JR; Teng CJ
    Hematol Oncol; 2023 Aug; 41(3):499-509. PubMed ID: 36790759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.
    Farge T; Saland E; de Toni F; Aroua N; Hosseini M; Perry R; Bosc C; Sugita M; Stuani L; Fraisse M; Scotland S; Larrue C; Boutzen H; Féliu V; Nicolau-Travers ML; Cassant-Sourdy S; Broin N; David M; Serhan N; Sarry A; Tavitian S; Kaoma T; Vallar L; Iacovoni J; Linares LK; Montersino C; Castellano R; Griessinger E; Collette Y; Duchamp O; Barreira Y; Hirsch P; Palama T; Gales L; Delhommeau F; Garmy-Susini BH; Portais JC; Vergez F; Selak M; Danet-Desnoyers G; Carroll M; Récher C; Sarry JE
    Cancer Discov; 2017 Jul; 7(7):716-735. PubMed ID: 28416471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
    Thakral D; Gupta R; Khan A
    Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
    Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
    PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia.
    Thakral D; Singh VK; Gupta R; Jha N; Khan A; Kaur G; Rai S; Kumar V; Supriya M; Bakhshi S; Seth R
    Ann Hematol; 2023 Jan; 102(1):73-87. PubMed ID: 36527458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia.
    Laverdière I; Boileau M; Neumann AL; Frison H; Mitchell A; Ng SWK; Wang JCY; Minden MD; Eppert K
    Blood Cancer J; 2018 Jun; 8(6):52. PubMed ID: 29921955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cells of leukemic stem cell origin with non-canonical regenerative properties.
    Hollands CG; Boyd AL; Zhao X; Reid JC; Henly C; ElRafie A; Boylan D; Broder E; Kalau O; Johnson P; Mark A; McNicol J; Xenocostas A; Berg T; Foley R; Trus M; Leber B; Garcia-Horton A; Campbell C; Bhatia M
    Cell Rep Med; 2024 Apr; 5(4):101485. PubMed ID: 38582086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities.
    O'Reilly E; Zeinabad HA; Szegezdi E
    Blood Rev; 2021 Nov; 50():100850. PubMed ID: 34049731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker.
    Jan M; Chao MP; Cha AC; Alizadeh AA; Gentles AJ; Weissman IL; Majeti R
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5009-14. PubMed ID: 21383193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
    de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
    Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Lin CC; Yao CY; Hsu YC; Hou HA; Yuan CT; Li YH; Kao CJ; Chuang PH; Chiu YC; Chen Y; Chou WC; Tien HF
    Oncogene; 2020 Jul; 39(28):5112-5123. PubMed ID: 32533098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.
    Ragusa M; Avola G; Angelica R; Barbagallo D; Guglielmino MR; Duro LR; Majorana A; Statello L; Salito L; Consoli C; Camuglia MG; Di Pietro C; Milone G; Purrello M
    BMC Cancer; 2010 Jul; 10():377. PubMed ID: 20642818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD69 marks a subpopulation of acute myeloid leukemia with enhanced colony forming capacity and a unique signaling activation state.
    Antony ML; Chang D; Noble-Orcutt KE; Kay A; Jensen JL; Mohei H; Myers CL; Sachs K; Sachs Z
    Leuk Lymphoma; 2023; 64(7):1262-1274. PubMed ID: 37161853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
    Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM
    BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.